Advertisement

Ads Placeholder
Loading...

Veracyte, Inc.

VCYT•NASDAQ
Healthcare
Biotechnology
$32.25
$-0.15(-0.46%)
U.S. Market opens in 45h 37m

Veracyte, Inc. (VCYT) Stock Overview

Explore Veracyte, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.6B
P/E Ratio38.48
EPS (TTM)$0.82
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$31.74
3 Months$25.15
1 Year Target$45.32

VCYT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Veracyte, Inc. (VCYT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.60, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $45.32.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 38.48 and a market capitalization of 2.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.46%
5-Day Change
-0.43%
1-Month Change
-8.07%
3-Month Change
-23.92%
6-Month Change
-10.42%
Year-to-Date (YTD) Change
-23.92%
1-Year Change
13.28%
3-Year Change
45.47%
5-Year Change
-43.04%
All-Time (Max) Change
143.40%

Contact Information

https://www.veracyte.com
650 243 6300
6000 Shoreline Court, South San Francisco, CA, 94080

Company Facts

8,240 Employees
IPO DateOct 30, 2013
CountryUS
Actively Trading

Frequently Asked Questions